Human rabies immunoglobulin Market: Global Industry Research Report 2020-2027 | Envisage Research

Human rabies immunoglobulin Market - By Type (ERIG & HRIG) and By Application (Category II Exposure and Category III Exposure) and By Region (North America, Europe, Asia-Pacific, LMEA, Middle East and Africa) - Industry Analysis, opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 196

Status: Published

Report Code: EMR100339

Human Rabies Immunoglobulin Market was valued at USD 285 Million in 2020 and is forecasted to value over USD 500 million by 2027 end and register a CAGR of 8.4% from the forecast period 2020-2027. Gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

Rabies is a zoonotic viral disease caused due to animal bits. The disease is known to affect domestic as well as wild animals such as bats, skunks, foxes, ferrets, raccoons, cats, or dogs, and infects humans upon contact with saliva of infected animal. Rabies is known to have an incubation period of one to three months. Individuals suffering from rabies show initial symptoms of fever and pain or tingling or burning sensation also called as paraesthesia at the wound site. As the disease progresses through the central nervous system (CNS), patients exhibit hyperactivity, excited behaviour, hydrophobia.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

One of the restraining factors which affects the growth of the global market for human rabies immunoglobulin market is the absence of a predefined regulatory framework is substantially hindering the inflow of the demand for human rabies immunoglobulin. Nevertheless, the market for human rabies immunoglobulin is rapidly evolving with a growing preference for point-of-care testing as well as personalized medicine and the advent of cost-effective lab tests and integrated analytical systems are expected to open new opportunities for the merchants of this market.

The key players in global human rabies immunoglobulin market includes CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, CNBG, Kamada, CBPO, Shuanglin Bio Weiguang Bio, Bharat Serum, Shanghai RAAS, VINS.

Analyst commentary

The market is also expected to benefit from the vast rise in funding from government, public, and private bodies towards the pharmaceutical industry to develop an effective cure for the vast number of chronic diseases affecting the global population. Stringent regulations about the safety of drug development processes and efficiency of quality control and quality assurance guidelines governing the pharmaceutical and associated industries in a number of developed economies also drive the global human rabies immunoglobulin market.

Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players.
The market players from Human Rabies Immunoglobulin market are anticipated to lucrative growth opportunities in the future with the rising demand for Human Rabies Imunoglobulin market in the global market.

Segmentation

The global human rabies immunoglobulin market is segmented on the basis of type and application.
When it comes to bifurcation on the basis of type the global human rabies immunoglobulin market is segmented into ERIG & HRIG. Furthermore, segmentation on the basis of application the market is bifurcated into Category II Exposure and Category III Exposure.
Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and shared a major proportion in 2017
The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG was major in 2017 .

Regional Analysis

From a geographical standpoint, the global Human Rabies Immunoglobulin market has been examined in the report for regions such as Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa. Of these, the market in North America has remained at the forefront in terms of growth opportunities as well as developments in the field of Human Rabies Immunoglobulin over the years. The region is likely to continue to account for a significant piece of the revenue pie over the next few years as well, thanks to the presence of several pharmaceutical and biosciences companies and the presence of numerous leading players in the field of Human Rabies. China is the largest sales place, and dominated the market share ,the reason being that China having a mammoth population.
WHO statistics also show that although rabies is prevalent in all continents except Antarctica, more than 95% of the mortalities occur in African and Asian countries. Rabies infections are common in areas where human-animal interaction is more and no proper medical treatment facility is available for treatment. In the U.S. only 55 cases have been identified since 1955 according to Centres for Disease Control and Prevention (CDC). Rapid diagnostic tests are available for diagnosis of rabies. These tests are usually Enzyme Linked Immunosorbent Assay (ELISA) or fluorescent assay technology. Synbiotics Corporation, O.K. SERVIS BioPro, s.r.o., Bio-Rad Laboratories, Inc. and Alpha Diagnostic International are some of the players manufacturing diagnostic kits for rabies. Immunoglobulin.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Rabies Immunoglobulin Market
Chapter 5. Global Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
5.1. Global Rabies Immunoglobulin Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. ERIG
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. HRIG
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (Volume/Units) (USD Million)
6.1. Rabies Immunoglobulin Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Category II Exposure
6.1.1.1. Market Size and projections,2015 - 2027 (Volume/Units) (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Category III Exposure
6.1.2.1. Market Size and projections,2015 – 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Rabies Immunoglobulin Market Overview, By Geography, 2015 - 2027 (Volume/Units) (USD Million)
7.1. Rabies Immunoglobulin Market Share, By Geography, 2015 - 2027 (Volume/Units) (USD Million)
7.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 8. North America Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (Volume/Units) (USD Million)
8.1. North America Rabies Immunoglobulin Market Overview, 2015 - 2027 (USD Million)
8.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.3. North America Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
8.1.4. North America Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Rabies Immunoglobulin Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Rabies Immunoglobulin Market Overview, By Application,2015 - 2027 (USD Million)
8.1.4.2. Canada Rabies Immunoglobulin Market Overview, 2015 - 2027 (Volume/Units) (USD Million)
8.1.4.2.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
8.1.4.2.2. Canada Rabies Immunoglobulin Market Overview, By Type, 2015 – 2027 (USD Million)
8.1.4.2.3. Canada Rabies Immunoglobulin Market Overview, By Application,2015 - 2027 (USD Million)
8.1.4.3. Mexico Rabies Immunoglobulin Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Rabies Immunoglobulin Market Overview, By Application,2015 - 2027 (USD Million)
Chapter 9. Europe Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (Volume/Units) (USD Million)
9.1. Europe Rabies Immunoglobulin Market Overview, 2015 – 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (Volume/Units) (USD Million)
9.1.2. Europe Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. Europe Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. Europe Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.1.3. Germany Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4.2. France
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. France Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.2.3. France Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4.3. UK
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. UK Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.3.3. UK Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Italy Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.4.3. Italy Rabies Immunoglobulin Market Overview, By Application 2015 - 2027 (USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.5.2. Spain Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.5.3. Spain Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market size and projections, 2015 – 2025
9.1.4.6.2. Rest of Europe Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.6.3. Rest of Europe Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 10. Asia Pacific Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Asia Pacific Rabies Immunoglobulin Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Asia Pacific Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Asia Pacific Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Asia Pacific Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. India Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.1.3. India Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.2.2. China Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.2.3. China Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. Japan Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.3.3. Japan Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.4.2. South Korea Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (Volume/Units) (USD Million)
10.1.4.4.3. South Korea Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.5.3. Rest of Asia Pacific Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 11. Middle East & Africa Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Middle East & Africa Rabies Immunoglobulin Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Middle East & Africa Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Middle East & Africa Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Middle East & Africa Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. GCC Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.1.3. GCC Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. South Africa Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.2.3. South Africa Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 12. South America Rabies Immunoglobulin Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. South America Rabies Immunoglobulin Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. South America Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. South America Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. South America Rabies Immunoglobulin Market Overview, By Countries, 2015- 2026 (USD Million)
12.1.5. Brazil
12.1.5.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.5.2. Brazil Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.3. Brazil Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.6. Argentina
12.1.6.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.6.2. Argentina Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.6.3. Argentina Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.7. Rest of South America
12.1.7.1. Market size and projections, 2015 – 2026
12.1.7.2. Rest of South America Rabies Immunoglobulin Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.7.3. Rest of South America Rabies Immunoglobulin Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Type development
Chapter 14. Key Vendor Analysis
14.1. CSL Behring.
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Type Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Sanofi.
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Type Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Grifols.
14.4. Sichuan Yuanda Shuyang.
14.5. CNBG.
14.6. Kamada.
14.7. Shuanglin Bio Weiguang Bio.
14.8. Bharat Serum.
14.9. Shanghai RAAS.
14.10. VINS.
Chapter 15. Rabies Immunoglobulin Market Cost Analysis
15.1. Rabies Immunoglobulin Market Key Raw Materials Analysis
15.1.1. Key Raw Materials
15.1.2. Price Trend of Key Raw Materials
15.1.3. Key Suppliers of Raw Materials
15.1.4. Market Concentration Rate of Raw Materials
15.2. Proportion of Wing Cost Structure
15.2.1. Raw Materials
15.2.2. Labor Cost
15.2.3. Wing Expenses
15.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 16. Chain, Sourcing Strategy and Downstream Buyers
16.1. Rabies Immunoglobulin Market Chain Analysis
16.2. Upstream Raw Materials Sourcing
16.3. Raw Materials Sources of Rabies Immunoglobulin Market Major Manufacturers in 2019
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Type Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Type Progress in Related Industry
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Rabies Immunoglobulin Market share, by Type, 2020 & 2027 (%)
10. Global Rabies Immunoglobulin Market share, by Type 2020 & 2027 (USD Million)
11. Global Rabies Immunoglobulin Market share, by Application, 2020 & 2027 (%)
12. Global Rabies Immunoglobulin market share, by Category II Exposure, by Application, 2020 & 2027 (USD Million)
13. Global Rabies Immunoglobulin market share, by Category III Exposure, by Application, 2020 & 2027 (USD Million)
14. Global Rabies Immunoglobulin market share, by region, 2020 - 2027(%)
15. Global Rabies Immunoglobulin market share, by region, 2019 - 2027(USD Million)
16. North America Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
17. North America Rabies Immunoglobulin Market share, by Countries, 2020 & 2027 (%)
18. U.S. Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
19. Canada Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
20. Europe Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
21. Europe Rabies Immunoglobulin Market share, by Countries, 2020 & 2027 (%)
22. Spain Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
23. UK Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
24. Italy Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
25. Germany Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
26. France Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
27. Rest of Europe Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
28. Asia-Pacific Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
29. Asia-Pacific Rabies Immunoglobulin Market share, by Countries, 2020 & 2027 (%) China Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
30. India Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
31. Australia Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
32. Japan Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
33. Rest of Asia-Pacific Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
34. Middle East & Africa Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
35. Middle East & Africa Rabies Immunoglobulin Market share, by Countries, 2020 & 2027 (%)
36. GCC Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
37. South Africa Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
38. Rest Of Middle East & Africa Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
39. South America Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
40. Brazil Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
41. Mexico Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
42. Argentina Rabies Immunoglobulin Market, 2020 - 2027(USD Million)
43. Rest Of South America Rabies Immunoglobulin Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Rabies Immunoglobulin Market, 2020-2027 (USD Million)
4. Rabies Immunoglobulin requirement, by country, 2020-2027, (USD Million)
5. North America Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
6. North America Rabies Immunoglobulin Market, by Application, 2020-2027 (USD Million)
7. North America Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
8. Europe Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
9. Europe Rabies Immunoglobulin Market, by Application, 2020-2027 (USD Million)
10. Europe Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
11. Asia Pacific Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
12. Asia Pacific Rabies Immunoglobulin Market, by Application, 2020-2027 (USD Million)
13. Asia Pacific Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
14. Middle East & Africa Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
15. Middle East & Africa Rabies Immunoglobulin Market, by Application, 2020-2027 (USD Million)
16. Middle East & Africa Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
17. South America Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
18. South America Rabies Immunoglobulin Market, by Application, 2020-2027 (USD Million)
19. South America Rabies Immunoglobulin Market, by Type, 2020-2027 (USD Million)
20. Global Rabies Immunoglobulin Market, Company Market Share, 2018 (%)
21. CSL Behring: Product Benchmarking
22. CSL Behring: Financial Performance
23. Sanofi: Product Benchmarking
24. Sanofi: Financial Performance
25. Grifols.: Product Benchmarking
26. Grifols.: Financial Performance
27. Sichuan Yuanda Shuyang: Product Benchmarking
28. Sichuan Yuanda Shuyang: Financial Performance
29. CNBG: Product Benchmarking
30. CNBG: Financial Performance
31. Kamada: Product Benchmarking
32. Kamada: Financial Performance
33. Shuanglin Bio Weiguang Bio: Product Benchmarking
34. Shuanglin Bio Weiguang Bio: Financial Performance
35. Bharat Serum: Product Benchmarking
36. Bharat Serum: Financial Performance
37. Shanghai RAAS.: Product Benchmarking
38. Shanghai RAAS.: Financial Performance
39. VINS: Product Benchmarking
40. VINS: Financial Performance

The Leading Key Players in Human Rabies Immunoglobulin Market

CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio Weiguang Bio
Bharat Serum
Shanghai RAAS
VINS.